As of 30 Sep 2025, 51 institutional investors reported holding $1,120,296,300 in principal (par value) of DEXCOM INC - NOTE 0.250%11/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $0 | $0 | -$23,813,579 | 0 | |
| 2025 Q3 | $1,120,296,300 | $1,116,520,040 | +$18,879,580 | 99.31% | 51 |
| 2025 Q2 | $1,167,328,550 | $1,147,840,413 | +$2,043,142 | 98.12% | 55 |
| 2025 Q1 | $1,172,568,237 | $1,142,540,195 | +$42,256,990 | 97.33% | 62 |
| 2024 Q4 | $1,187,376,050 | $1,144,950,630 | -$53,822,835 | 96.25% | 78 |
| 2024 Q3 | $1,204,953,877 | $1,149,454,611 | +$45,722,170 | 95.35% | 82 |
| 2024 Q2 | $1,152,558,262 | $1,155,243,364 | +$19,120,843 | 100.06% | 91 |
| 2024 Q1 | $1,127,054,910 | $1,240,355,204 | -$7,566,820 | 109.85% | 89 |
| 2023 Q4 | $1,134,671,973 | $1,188,160,145 | +$7,134,212 | 104.47% | 90 |
| 2023 Q3 | $1,145,104,964 | $1,082,783,537 | -$24,880,315 | 94.37% | 89 |
| 2023 Q2 | $1,165,989,160 | $1,248,508,965 | -$86,545,027 | 106.75% | 72 |
| 2023 Q1 | $1,245,990,160 | $1,340,051,257 | +$3,462,766 | 107.12% | 70 |
| 2022 Q4 | $1,239,584,500 | $1,351,327,623 | -$276,972,312 | 108.75% | 70 |
| 2022 Q3 | $1,191,592,700 | $1,103,394,687 | -$34,722,981 | 92.61% | 66 |
| 2022 Q2 | $1,230,225,170 | $1,130,276,718 | -$28,967,698 | 91.6% | 64 |
| 2022 Q1 | $1,281,219,170 | $1,470,163,998 | +$68,390,488 | 114.67% | 63 |
| 2021 Q4 | $1,187,322,700 | $1,407,864,733 | +$387,249,486 | 118.69% | 61 |
| 2021 Q3 | $860,621,770 | $1,026,952,459 | -$92,472,737 | 118.86% | 59 |
| 2021 Q2 | $951,887,000 | $997,195,198 | +$994,636,852 | 104.59% | 56 |